Comorbidities of hidradenitis suppurativa (acne inversa)

Dermato-Endocrinology

Volumn 2, Issue 1, 2010, Pages 9-16

  Fimmel, Sabine ^a   Zouboulis, Christos C ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

Author keywords

Acne inversa; Autoimmune diseases; Autoinflammatory disorders; Crohn disease; Follicular occlusion; Hidradentitis suppurativa; Spondylarthropathy; Th17 cell cytokines

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA;

BEHCET DISEASE; COCHRANE LIBRARY; COMORBIDITY; CONGENITAL PACHYONYCHIA; CROHN DISEASE; DISEASE ASSOCIATION; DOWN SYNDROME; EMBASE; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; MEDLINE; PYODERMA GANGRENOSUM; REVIEW; SAPHO SYNDROME; SPONDYLOARTHROPATHY; SQUAMOUS CELL CARCINOMA; SUPPURATIVE HIDRADENITIS; TH17 CELL; ULCERATIVE COLITIS;

EID: 77956320507     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.2.1.12490     Document Type: Review

References (154)

1. Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17:455-72.
2. Velpeau A. Aissele. In: Bechet Jeune Z, ed. Dictionnaire de médecine, un repertoire générale des Sciences Medicals sous le rapport theorique et pratique. Paris 1839; 2:1839-91.
3. Verneuil A. Etudes sur les tumeurs de la peau; de quelques maladies des glandes sudoripares. Arch Gen Med 1854; 4:447-68.
4. Brunsting HA. Hidradenitis suppurativa; abscess of apocrine sweat glands - a study of the clinical and pathologic features with a report of twenty-two cases and a review of the literature. Arch Dermatol Syphilol 1939; 39:108-20.
5. st ed. Philadelphia: Saunders WB 1956; 482-4.
6. Plewig G, Kligman AM. Acne: Morphogenesis and Treatment. Berlin: Springer-Verlag 1975; 192-3.
7. Plewig G, Steger M. Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). In: Marks R, Plewig G, eds. Acne and related disorders. London: Martin Dunitz 1989; 345-57.
8. Sellheyer K, Krahl D. What causes acne inversa (or hidradenitis suppurativa)? - the debate continues. J Cutan Pathol 2008; 35:795-7.
9. Jemec GB, Thomsen BM, Hansen U. The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS 1997; 105:378-83.
10. Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996; 34:994-9.
11. Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990; 122:763-9.
12. Von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol 2010; 19:533-7.
13. Kelekis NL, Efstathopoulos E, Balanika A, Spyridopoulos TN, Pelekanou A, Kanni T, et al. Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa. Br J Dermatol 2010; 162:1400-2.
14. Wortsman XC, Jemec GB. Real-time compound imaging ultrasound of hidradenitis suppurativa. Dermatol Surg 2007; 33:1340-2.
15. Jemec GB, Gniadecka M. Ultrasound examination of hair follicles in hidradenitis suppurativa. Arch Dermatol 1997; 133:967-70.
16. Wortsman XC, Holm EA, Wulf HC, Jemec GB. Real-time spatial compound ultrasound imaging of skin. Skin Res Technol 2004; 10:23-31.
17. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, Mouktaroudi M, Spyridaki E, Baziaka F, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 2007; 156:51-6.
18. Hunger RE, Surovy AM, Hassan AS, Braathen LR, Yawalkar N. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 2008; 158:691-7.
19. van der Zee HH, Boer J, Prens EP, Jemec GBE. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219:143-7.
20. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: A series of 116 consecutive patients. Dermatology 2009; 219:148-54.
21. th ed, McGraw Hill, New York Chicago 2009; Online update 7e.
22. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol 2010; 62:205-17.
23. Haslund P, Lee RA, Jemec GB. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venerol 2009; 89:595-600.
24. Lee RA, Dommasch E, Treat J, Sciacca-Kirby J, Chachkin S, Williams J, et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2009; 60:565-73.
25. Revuz J. Hidradenitis suppurativa. JEADV 2009; 23:985-98.
26. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: A comprehensive review. J Am Acad Dermatol 2009; 60:539-61.
27. Hidradenitis Suppurativa Foundation (HSF). www.hs-foundation.org.
28. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk RK, Roenigk HH Jr, eds. Dermatologic Surgery. Principles and Practice. New York: Marcel Dekker 1996; 2:623-45.
29. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003; 149:211-3.
30. Revuz J. Modifications et mode d'emploi du score de Sartorius pour évaluer la gravité de l'hidradédnite suppurée. Ann Dermatol Venereol 2007; 134:173-80.
31. Sartorius K, Emtestam L, Jemec GBE, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009; 161:831-9.
32. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 5:596-601.
33. Naldi L. Epidemiology. In: Jemec G, Revuz J, Leyden J, eds. Hidradenitis suppurativa. Berlin Springer 2006; 1:58-64.
34. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35:191-4.
35. Sartorius K, Killasli H, Heilborn J, Jemec GB, Lapins J, Emtestam L. Interobserver variability of clinical scores in hidradenitis suppurativa is low. Br J Dermatol 2010; In press.
36. Fitzsimmons JS, Fitzsimmons EM, Gilbert G. Familial Hidradenitis suppurativa: Evidence in favor of single gene transmission. J Med Genet 1984; 21:281-5.
37. Fitzsimmons JS, Gilbert PR. A family study of Hidradenitis suppurativa. J Med Genet 1985; 22:367-73.
38. von der Werth J, Wood P, Irvine AD, Mc Lean HW. Genetics of hidradenitis suppurativa. Berlin Heidelberg: Springer 2006; 70-85.
39. Gao M, Wang PG, Cui Y, Yang S, Zhang YH, Lin D, et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol 2006; 126:1302-6.
40. Hurley HJ. Apocrine glands. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, (eds). Dermatology in General Medicine. New York: McGraw-Hill 1993; 4:753-66.
41. Baughman SM, Cespedes RD. Unusual presentation of hidradenitis suppurativa with massive enlargement of penis. Urology 2004; 64:37719-20.
42. Caaliskan Y, Yazici H, Kucuk M, Alisir S, Kilicaslan I, Ecder T. Nephrotic syndrome associated with hidradenitis suppurativa. Clin Nephrol 2005; 63:171-2.
43. Titze J, Schneider M, Krause H, Jacobi J, Stolte M, Linke RP, et al. Diarrhea, nephrotic syndrome and hidradenitis suppurativa: an unusual case. Nephrol Dial Transplant 2003; 18:192-4.
44. Rosenweig LB, Brett AS, Lefaivre J, Vandersteenhoven JJ. Hidradenitis suppurativa complicated by squamous cell carcinoma and paraneoplastic neuropathy. Am J Med Sci 2005; 329:150-2.
45. Williams ST, Busby RC, DeMuth RJ, Nelson H. Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg 1991; 26:456-62.
46. Chalmers RJ, Ead RD, Beck MH, Dewis P, Anderson DC. Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J 1983; 287:1346-7.
47. Roy MK, Appleton MAC, Delicata RJ, Sharma AK, Williams GT, Carey PD. Probable association between hidradenitis suppurativa and Crohn's disease: significance of epithelioid granuloma. Br J Surg 1997; 84:375-6.
48. Attanoos RL, Appleton MA, Hughes LE, Ansell ID, Douglas-Jones AG, Williams GT. Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease. Histopathology 1993; 23:111-5.
49. Scheinfeld N. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab. J Am Acad Dermatol 2006; 55:163-4.
50. Bleiziffer O, Dragu A, Kneser U, Horch RE. Solving acne inversa (hidradenitis suppurativa) in Crohn disease with buried chip skin grafts. J Cutan Med Surg 2009; 13:164-8.
51. Goertz RS, Konturek PC, Naegel A, Janka R, Amann K, Maennlein G, et al. Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease. Med Sci Monit 2009; 15:14-8.
52. Goischke HK, Ochsendorf FR. Acne inversa in Crohn's disease. Z Gastroenterol 2001; 39:96553-9.
53. Moschella SL. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases. Int J Dermatol 2007; 46:1287-91.
54. Martinez F, Nos P, Benlloch S, Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis 2001; 7:323-6.
55. Katsanos KH, Chistodoulou DK, Tsianos E. Axillary hidradentis suppurativa treated with infliximab in a Crohn's disease patient. Am J Gastroenterol 2002: 97:2155-6.
56. Roussomoustakaki M, Dimoulios P, Chatzicostas C, Kritikos HD, Romanos J, Panayiotides JG, et al. Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy. J Gastroenterol 2003; 38:1000-4.
57. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatol Treat 2005; 16:58-61.
58. Tsianos EV, Dalekos GN, Tzermias C, Merkouropoulos M, Hatzis J. Hidradenitis suppurativa in Crohn's disease. A further support to this association. J Clin Gastroenterol 1995; 20:151-3.
59. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis 1993; 8:117-9.
60. Gheorghe C, Cotruta B, Trifu V, Grasu M, Gheorghe L. Perineal abscesses and fistulas - always a mark of Crohn's disease? J Gastrointestin Liver Dis 2007; 16:307-8.
61. Kelly AM, Cronin P. MRI features of hidradenitis suppurativa and review of the literature. AJR Am J Roentgenol 2005; 185:1201-4.
62. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2003; 49:275-6.
63. Carvalho P, Cordel N, Courville P, Leloet X, Heron F, Lauret P, et al. Cutaneous aseptic abscesses, manifestations of neutrophilic diseases. Ann Dermatol Venereol 2001; 128:641-3.
64. Ostlere LS, Langtry JA, Mortimer PS, Staughton RC. Hidradenitis suppurativa in Crohn's disease. Br J Dermatol 1991; 125:384-6.
65. Rajpara SM, Siddha SK, Ormerod AD, Kerr KM, Kolhe PS. Cutaneous penile and perianal Crohn's disease treated with a combination of medical and surgical interventions. Australas J Dermatol 2008; 49:21-4.
66. Teixeira M, Machado S, Lago P, Sanches M, Selores M. Cutaneous Crohn's disease. Int J Dermatol 2006; 45:1074-6.
67. Barreales M, Laluela A, Manzano M, González C, Solís Herruzo JA. A perianal condition treated for Acne conglobata as initial Crohn's disease. Rev Esp Enferm Dig 2007; 99:46-7.
68. Hindersin S, Mönnighoff I, Schipper J, Hoffmann TK. Metastatic Crohn's disease: manifestation in head and neck region. Laryngorhinootologie 2009; 88:112-5.
69. Emanuel PO, Phelps RG. Metastatic Crohn's disease: a histopathologic study of 12 cases. J Cutan Pathol 2008; 35:457-61.
70. Jiménez Rodríguez RM, Argüelles Solido E, Marcilla Plaza D, González Resina R, Lozano Blasco JM, Campoy Martínez P. Metastatic Crohn's disease involving the penile foreskin. Arch Esp Urol 2006; 59:902-5.
71. Yu JT, Chong LY, Lee KC. Metastatic Crohn's disease in a Chinese girl. Hong Kong Med J 2006; 12:467-9.
72. Martín de Carpi J, Chávez Caraza K, Vicente Villa MA, González Enseñat MA, Vilar Escrigas P, Vila Miravet V, et al. Skin manifestations of pediatric inflammatory bowel disease. A Pediatr 2009; 70:570-7.
73. Eames T, Landthaler M, Karrer S. Crohn's disease: an important differential diagnosis of granulomatous skin diseases. Eur J Dermatol 2009; 19:360-4.
74. Short KA, Kalu G, Mortimer PS, Higgins EM. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Clin Exp Dermatol 2005; 30:481-3.
75. Legrand E, Audran M, Rousselet-Chapeau MC, Le Levier F, Brithmer L, Vigouroux B, et al. Iliac osteosarcoma in a patient with SAPHO syndrome. Rev Rhum Engl Ed 1995; 62:139-41.
76. Steinhoff JP, Cilursu A, Falasca GF, Guzman L, Reginato AJ. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol 2002; 8:13-22.
77. Ozyemisci-Taskiran O, Bölükbasi N, Gögüs F. A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria. Clin Rheumatol 2007; 26:789-91.
78. Shenefelt PD. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis 1996; 57:315-9.
79. Ah-Weng JA, Langtry S, Velangi S, Evans CD, Douglas WS. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol 2005; 30:669-71.
80. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behçet's disease. Yonsei Med J 2007; 48:573-85.
81. Bilic M, Mutasim DF. Neutrophilic eccrine hidradenitis in a patient with Behçet's disease. Cutis 2001:68:107-11.
82. Nijsten TE, Meuleman L, Lambert J. Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease. Br J Dermatol 2002; 47:797-800.
83. Mercader-García P, Vilata-Corell JJ, Pardo-Sanchez J, Fortea-Baixauli JM. Neutrophilic eccrine hidradenitis in a patient with Behçet's disease. Acta Derm Venereol 2003; 83:395-6.
84. Sahin MT, Oztürkcan S, Türel-Ermertcan A, Yurtman-Havlucu D, Bilaç C. Behçet's disease associated with hidradenitis suppurativa. JEADV 2007; 21:428-9.
85. Rosner IA, Burg CG, Wisnieski JJ, Schacter BZ, Richter DE. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and Acne conglobata. J Rheumatol 1993; 20:684-7.
86. Bhalla R, Sequeira W. Arthritis associated with hidradenitis suppurativa. Ann Rheum Dis 1994; 53:64-6.
87. Alba D, Torres E, Ripoll MM, Molina F. Reactive arthritis and hidradenitis suppurativa. Ann Med Interna 1995; 12:464-5.
88. Hamoir XL, François RJ, Van den Haute V, Van Campenhoudt M. Arthritis and hidradenitis suppurativa diagnosed in a 48-year-old man. Skeletal Radiol 1999; 28:453-6.
89. Abid N, Opran A, Rosner F. Hidradenitis suppurativa complicated by erosive arthropathy and ulcerative keratitis. J Clin Rheumatol 1999; 5:29-31.
90. Marquardt AL, Hackshaw KV. Reactive arthritis associated with hidradenitis suppurativa. J Natl Med Assoc 2009; 101:367-9.
91. Leybishkis B, Fasseas P, Ryan KF, Roy R. Hidradenitis suppurativa and Acne conglobata associated with spondyloarthropathy. Am J Med Sci 2001; 321:195-7.
92. Ellis BI, Shier CK, Leisen JJ, Kastan DJ, McGoey JW. Acne-associated spondylarthropathy: radiographic features. Radiology 1987; 162:541-5.
93. Olafsson S, Khan MA. Musculoskeletal features of acne, hidradenitis suppurativa and dissecting cellulitis of the scalp. Rheum Dis Clin North Am 1992; 18:215-24.
94. Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis 1999; 64:87-90.
95. Thein M, Hogarth MB, Acland K. Seronegative arthritis associated with the follicular occlusion triad. Clin Exp Dermatol 2004; 29:550-2.
96. Todd P, Garioch J, Rademaker M, Susskind W, Gemell C, Thomson J. Pachyonychia congenita complicated by hidradenitis suppurativa: a family study. Br J Dermatol 1990; 123:663-6.
97. Smith FJ, Corden LD, Rugg EL, Ratnavel R, Leigh IM, Moss C, et al. Missense mutations in keratin 17 cause either Pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108:220-3.
98. Oh SW, Kim MY, Lee JS, Kim SC. Keratin 17 mutation in Pachyonychia congenita type 2 patient with early onset steatocystoma multiplex and Hutchinson-like tooth deformity. J Dermatol 2006; 33:161-4.
99. Pedraz J, Peñas PF, Garcia-Diez A. Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy. JEADV 2008; 22:1500-1.
100. McDonald RM, Reed WB. Natal teeth and steatocystoma multiplex complicated by hidradenitis suppurativa. A new syndrome. Arch Dermatol 1976; 112:1132-4.
101. Fenske NA, Groover CE, Lober CW, Espinoza CG. Dowling-Degos disease, hidradenitis suppurativa and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. J Am Acad Dermatol 1991; 24:888-92.
102. Balus L, Fazio M, Amantea A, Menaguale G. Dowling-Degos disease and Verneuil disease. Ann Dermatol Venereol 1993; 120:705-8.
103. Bedlow AJ, Mortimer PS. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol 1996; 21:305-6.
104. Kleeman D, Trüeb RM, Schmid-Grendelmeier P. Reticular pigmented anomaly of the flexures. Dowling-Degos disease of the intertrigo type in association with acne inversa. Hautarzt 2001; 52:642-5.
105. Loo WJ, Rytina E, Todd PM. Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad. Clin Exp Dermatol 2004; 29:622-4.
106. Dixit R, George R, Jacob M, Sudarsanam TD, Danda D. Dowling-Degos disease, hidradenitis suppurativa and arthritis in mother and daughter. Clin Exp Dermatol 2006; 31:454-6.
107. Weber LA, Kantor GR, Bergfeld WF. Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma. Cutis 1990; 45:446-50.
108. Li M, Hunt MJ, Commens CA. Hidradenitis suppurativa, Dowling Degos disease and perianal squamous cell carcinoma. Australas J Dermatol 1997; 38:209-11.
109. Maintz L, Betz RC, Allam JP, Wenzel J, Jaksche A, Friedrichs N, et al. Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol 2005; 15:347-52.
110. Montgomery JR, White TW, Martin BL, Turner ML, Holland SM. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis- deafness syndrome and the follicular occlusion triad. J Am Acad Dermatol 2004; 51:377-82.
111. Nyquist GG, Mumm C, Grau R, Crowson AN, Shurman DL, Benedetto P, et al. Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients. Am J Med Genet A 2007; 143:734-41.
112. Borbujo Martínez J, Bastos Amigo J, Olmos Carrasco O, San José Hugenot I, Toribio Dapena R, Casado Jímenez M. Suppurative hidradenitis in Down's syndrome. Apropos of three cases. An Esp Pediatr 1992; 36:59-61.
113. Talmant JC, Bruant-Rodier C, Nunziata AC, Rodier JF, Wilk A. Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review. Ann Chir Plast Esthet 2006; 51:82-6.
114. Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 2007; 89:709-12.
115. Kurokawa I, Nishimura K, Yamanaka K, Mizutani H, Tsubura A, Revuz J. Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). J Cutan Pathol 2007; 34:675-8.
116. Barresi V, Vitarelli E, Barresi G. Acne inversa complicated by squamous cell carcinoma in association with diffuse malignant peritoneal mesothelioma arising in the absence of predisposing factors: a case report. J Cutan Pathol 2008; 35:70-3.
117. Constantinou C, Widom K, Desantis J, Obmann M. Hidradenitis suppurativa complicated by squamous cell carcinoma. Am Surg 2008; 74:1177-81.
118. Katz RD, Goldberg NH. Marjolin ulcer arising within hidradenitis: a case report and literature review. Ann Plast Surg 2009; 62:173-4.
119. do Val IC, Almeida Filho GL, Corrêa A, Neto N. Chronic hidradenitis suppurativa and perianal mucinous adenocarcinoma. A case report. J Reprod Med 2007; 52:100-2.
120. Chicarilli ZN. Follicular occlusion triad: hidradenitis suppurativa, Acne conglobata and dissecting cellulitis of the scalp. Ann Plast Surg 1987; 18:230-7.
121. Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J 2003; 9:8.
122. von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000; 14:389-92.
123. Mortimer PS, Dawber RP, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J 1986; 292:245-8.
124. Jemec GB. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988; 119:345-50.
125. Jemec GB, Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology 1997; 194:325-8.
126. Dippel E, Rosenberger A, Zouboulis CC. Distant cutaneous manifestation of Crohn's disease presenting as a granulomatous erysipelas-like reaction. JEADV 1999; 12:65-6.
127. Zone JJ, LaSalle BA, Provost TT. Induction of IgA circulating immune complexes after wheat feeding in dermatitis herpetiformis patients. J Invest Dermatol 1982; 78:375-80.
128. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7.
129. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100:3455-60.
130. Behr MA, Semret M, Poon A, Schurr E. Crohn's disease, mycobacteria and NOD2. Lancet Infect Dis 2004; 4:136-7.
131. Wehkamp J, Stange EF. NOD2 mutation and mice: no Crohn's disease but many lessons to learn. Trends Mol Med 2005; 11:307-9.
132. Eckmann L, Karin M. NOD2 and Crohn's disease: loss or gain of function? Immunity 2005; 22:661-7.
133. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006; 25:473-85.
134. Nassar D, Hugot JP, Wolkenstein P, Revuz J. Lack of association between CARD15 gene polymorphisms and hidradenitis suppurativa: a pilot study. Dermatology 2007; 215:359.
135. Powell FC, Schroeter AL, Perry HO. Pyoderma gangrenosum. A review of 86 patients. Q J Med 1985; 217:173-86.
136. Schwaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT. Pyoderma gangrenosum: a review. J Am Acad Dermatol 1988; 18:559-68.
137. Lapins J, Asman B, Gustafsson A, Bergström K, Emtestam L. Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm Venerol 2001; 81:96-9.
138. Ginder PA, Ousley M, Hinthorn D, Liu C, Abdou NI. Hidradenitis suppurativa: evidence for a bactericidal defect correctable by cholinergic agonist in vitro and in vivo. J Clin Immunol 1982; 2:237-41.
139. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 2003; 192:149-55.
140. Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol 2006; 126:1534-40.
141. Harrist T, Fine JD, Berman RS, Murphy GF, Mihm MC Jr. Neutrophilic eccrine hidradenitis: a distinct type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 1982; 118:263-6.
142. Vasey FB, Fenske NA, Clement GB, Bridgeford PH, Germain BF, Espinoza LR. Immunological studies of the arthritis of Acne conglobata and hidradenitis suppurativa. Clin Exp Rheumatol 1984; 2:309-11.
143. Lapins J, Olerup O, Emtestam L. No human leukocyte antigen-A, -B or -DR association in Swedish patients with hidradenitis suppurativa. Acta Derm Venerol 2001; 81:28-30.
144. Lapins J, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 2001; 137:730-4.
145. Dvorak VC, Root RK, Macgregor RR. Host-defence mechanism in hidradenitis suppurativa. Arch Dermatol 1977; 113:450-3.
146. Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, et al. Autoinflammatory syndromes. Clin Exp Rheumatol 2006; 24:79-85.
147. Gadola SD. Interleukin-1-Zytokine, Inflammasome, NOD-Signalosome und Autoinflammation. Z Rheumatol 2009; 68:712-9.
148. Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology 2006; 45:1461-5.
149. Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: Bridging innate immunity and autoinflammation. Clin Immunol 2010; 134:251-61.
150. Meng G, Zhang F, Fuss I, Kitani A, Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009; 30:860-74.
151. Lamprecht P, Gross WL. Autoinflammatory syndromes. Internist 2009; 50:676-84.
152. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97:133-44.
153. Veillette A, Rhee I, Souza CM, Davidson D. PEST family phosphatases in immunity, autoimmunity and autoinflammatory disorders. Immunol Rev 2008; 228:312-24.
154. Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol Rev 2008; 226:160-71.